119 related articles for article (PubMed ID: 28415599)
21. High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer.
Bannon SA; Montiel MF; Goldstein JB; Dong W; Mork ME; Borras E; Hasanov M; Varadhachary GR; Maitra A; Katz MH; Feng L; Futreal A; Fogelman DR; Vilar E; McAllister F
Cancer Prev Res (Phila); 2018 Nov; 11(11):679-686. PubMed ID: 30274973
[No Abstract] [Full Text] [Related]
22. Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers.
Laitman Y; Keinan Boker L; Liphsitz I; Weissglas-Volkov D; Litz-Philipsborn S; Schayek H; Friedman E
Breast Cancer Res Treat; 2015 Apr; 150(3):631-5. PubMed ID: 25788227
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic cancer: BRCA mutation and personalized treatment.
Luo G; Lu Y; Jin K; Cheng H; Guo M; Liu Z; Long J; Liu C; Ni Q; Yu X
Expert Rev Anticancer Ther; 2015; 15(10):1223-31. PubMed ID: 26402249
[TBL] [Abstract][Full Text] [Related]
24. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
[TBL] [Abstract][Full Text] [Related]
25. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA
Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516
[TBL] [Abstract][Full Text] [Related]
26. Characterization of common BRCA1 and BRCA2 variants.
Deffenbaugh AM; Frank TS; Hoffman M; Cannon-Albright L; Neuhausen SL
Genet Test; 2002; 6(2):119-21. PubMed ID: 12215251
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations.
Khoo US; Ngan HY; Cheung AN; Chan KY; Lu J; Chan VW; Lau S; Andrulis IL; Ozcelik H
Hum Mutat; 2000 Jul; 16(1):88-9. PubMed ID: 10874312
[TBL] [Abstract][Full Text] [Related]
28. BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients.
Cecener G; Egeli U; Tunca B; Erturk E; Ak S; Gokgoz S; Tasdelen I; Tezcan G; Demirdogen E; Bayram N; Avci N; Evrensel T
Cancer Invest; 2014 Oct; 32(8):375-87. PubMed ID: 24884828
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
30. Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer.
Huang L; Wu C; Yu D; Wang C; Che X; Miao X; Zhai K; Chang J; Jiang G; Yang X; Cao G; Hu Z; Zhou Y; Zuo C; Wang C; Zhang X; Zhou Y; Yu X; Dai W; Li Z; Shen H; Liu L; Chen Y; Zhang S; Wang X; Liu Y; Sun M; Cao W; Gao J; Ma Y; Zheng X; Cheung ST; Jia Y; Tan W; Wu T; Lin D
Carcinogenesis; 2013 May; 34(5):1001-5. PubMed ID: 23299404
[TBL] [Abstract][Full Text] [Related]
31. Mutations in Known and Novel cancer Susceptibility Genes in Young Patients with Pancreatic Cancer.
Alimirzaie S; Mohamadkhani A; Masoudi S; Sellars E; Boffetta P; Malekzadeh R; Akbari MR; Pourshams A
Arch Iran Med; 2018 Jun; 21(6):228-233. PubMed ID: 29940740
[TBL] [Abstract][Full Text] [Related]
32. Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population.
Sekine M; Nagata H; Tsuji S; Hirai Y; Fujimoto S; Hatae M; Kobayashi I; Fujii T; Nagata I; Ushijima K; Obata K; Suzuki M; Yoshinaga M; Umesaki N; Satoh S; Enomoto T; Motoyama S; Tanaka K;
Clin Cancer Res; 2001 Oct; 7(10):3144-50. PubMed ID: 11595708
[TBL] [Abstract][Full Text] [Related]
33. BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA Testing.
Mitri ZI; Jackson M; Garby C; Song J; Giordano SH; Hortobágyi GN; Singletary CN; Hashmi SS; Arun BK; Litton JK
Oncologist; 2015 Jun; 20(6):593-7. PubMed ID: 25948675
[TBL] [Abstract][Full Text] [Related]
34. First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report.
Meynard G; Mansi L; Lebahar P; Villanueva C; Klajer E; Calcagno F; Vivalta A; Chaix M; Collonge-Rame MA; Populaire C; Algros MP; Colpart P; Neidich J; Pivot X; Curtit E
Oncol Rep; 2017 Mar; 37(3):1573-1578. PubMed ID: 28184945
[TBL] [Abstract][Full Text] [Related]
35. Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.
Zhong Q; Peng HL; Zhao X; Zhang L; Hwang WT
Clin Cancer Res; 2015 Jan; 21(1):211-20. PubMed ID: 25348513
[TBL] [Abstract][Full Text] [Related]
36. Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population.
Parvin S; Islam MS; Al-Mamun MM; Islam MS; Ahmed MU; Kabir ER; Hasnat A
Breast Cancer; 2017 Mar; 24(2):229-237. PubMed ID: 27068824
[TBL] [Abstract][Full Text] [Related]
37. Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG.
Soenderstrup IMH; Laenkholm AV; Jensen MB; Eriksen JO; Gerdes AM; Hansen TVO; Kruse TA; Larsen MJ; Pedersen IS; Rossing M; Thomassen M; Ejlertsen B
Acta Oncol; 2018 Jan; 57(1):95-101. PubMed ID: 29164974
[TBL] [Abstract][Full Text] [Related]
38. Association Between Family History and Risk of Pancreatic Cancer in Patients With BRCA1 and BRCA2 Pathogenic Variants.
Shah I; Silva-Santisteban A; Germansky KA; Kandasamy C; Mlabasati J; Huang DC; Wadhwa V; Bilal M; Sawhney MS
Pancreas; 2022 Aug; 51(7):733-738. PubMed ID: 36395396
[TBL] [Abstract][Full Text] [Related]
39. Association of BRCA Mutations and Pancreatic Cancer: Review of Literature and Meta-analysis.
Chandan S; Deliwala SS; Facciorusso A; Mohan BP; Ramai D; Kochhar GS
Pancreas; 2022 Jan; 51(1):e8-e10. PubMed ID: 35195609
[No Abstract] [Full Text] [Related]
40. A genetic variant in PIK3R1 is associated with pancreatic cancer survival in the Chinese population.
Zhu Y; Ke J; Gong Y; Yang Y; Peng X; Tian J; Zou D; Yang N; Wang X; Mei S; Rao M; Ying P; Deng Y; Wang H; Zhang H; Li B; Wan H; Li Y; Niu S; Cai Y; Zhang M; Lu Z; Zhong R; Miao X; Chang J
Cancer Med; 2019 Jul; 8(7):3575-3582. PubMed ID: 31059194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
